Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.

Aβ initiates brain hypometabolism, network dysfunction and behavioral abnormalities via NOX2-induced oxidative stress in mice

Open access

Published version of a preprint

Abstract

A predominant trigger and driver of sporadic Alzheimer’s disease (AD) is the synergy of brain oxidative stress and glucose hypometabolism starting at early preclinical stages. Oxidative stress damages macromolecules, while glucose hypometabolism impairs cellular energy supply and antioxidant defense. However, the exact cause of AD-associated glucose hypometabolism and its network consequences have remained unknown. Here we report NADPH oxidase 2 (NOX2) activation as the main initiating mechanism behind Aβ 1-42 -related glucose hypometabolism and network dysfunction. We utilize a combination of electrophysiology with real-time recordings of metabolic transients both ex- and in-vivo to show that Aβ 1-42 induces oxidative stress and acutely reduces cellular glucose consumption followed by long-lasting network hyperactivity and abnormalities in the animal behavioral profile. Critically, all of these pathological changes were prevented by the novel bioavailable NOX2 antagonist GSK2795039. Our data provide direct experimental evidence for causes and consequences of AD-related brain glucose hypometabolism, and suggest that targeting NOX2-mediated oxidative stress is a promising approach to both the prevention and treatment of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s42003-021-02551-x

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Aβ1-42 inhibits network glucose utilization. A In brain slices, 40 min of fibrillar Aβ1-42 application reduces network activity-driven glucose uptake. Left, example traces from a single experiment showing the extracellular glucose transients in CA1 pyramidal cell layer in response to a 10 Hz, 30 s stimulation of Schaffer collaterals (gray) in control (black) and following 40 min of Aβ1-42 application (red). Considering the constant 5 mM glucose supply from the perfusate, the drop in the transient amplitude indicates reduced uptake. Middle, summary graph showing glucose transient integral values normalized to controls. B In anesthetized mice, i.c.v. injection of fibrillar Aβ1-42 results in a rapid change in glucose uptake. (i) schematic depicting the relationship between the dynamic extracellular glucose supply from the blood (which increases following synaptic activation) and network glucose uptake. (ii) example traces from a single experiment showing both local field potential (LFP, orange) and extracellular glucose (black) recordings from the CA1 region before and after Aβ1-42 injection. (iii) detail of LFP recording showing characteristic anesthesia-induced oscillations (left) at baseline and the response to synaptic stimulation (right). (iv) average stimulation-induced glucose transients from a single experiment in control (black) and following i.c.v. Aβ1-42 injection (red) and summary graph showing glucose transient integral values normalized to controls for all experiments; (v) summary of LFP integrals showing that stimulation response did not change significantly following Aβ1-42 injection; this suggests that the activity-induced increase in glucose supply from the blood did not change, and therefore the apparent increase in glucose transients following Aβ1-42 injection indicates reduced uptake. C Aβ1-42 inhibits activity-driven glycolysis. Left, NAD(P)H autofluorescence traces from a single experiment in control (black) and following 40 min of Aβ1-42 application (red). Right, summary values of transient amplitudes both for the overshoot (glycolysis-related) and oxidation phases of the signal. D Aβ1-42 increases oxygen consumption: sample pO2 traces from a single experiment showing a transient decrease of tissue oxygen levels in control (black) and following 40 min of Aβ1-42 application (red) and a summary plot of normalized pO2 integral values. E Aβ1-42 does not significantly change the network response to synaptic stimulation: a summary plot of normalized LFP train integral values. Data are presented as box plots with min-max whiskers and Tukey quartile method. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Fig. 1 Aβ1-42 inhibits network glucose utilization. A In brain slices, 40 min of fibrillar Aβ1-42 application reduces network activity-driven glucose uptake. Left, example traces from a single experiment showing the extracellular glucose transients in CA1 pyramidal cell layer in response to a 10 Hz, 30 s stimulation of Schaffer collaterals (gray) in control (black) and following 40 min of Aβ1-42 application (red). Considering the constant 5 mM glucose supply from the perfusate, the drop in the transient amplitude indicates reduced uptake. Middle, summary graph showing glucose transient integral values normalized to controls. B In anesthetized mice, i.c.v. injection of fibrillar Aβ1-42 results in a rapid change in glucose uptake. (i) schematic depicting the relationship between the dynamic extracellular glucose supply from the blood (which increases following synaptic activation) and network glucose uptake. (ii) example traces from a single experiment showing both local field potential (LFP, orange) and extracellular glucose (black) recordings from the CA1 region before and after Aβ1-42 injection. (iii) detail of LFP recording showing characteristic anesthesia-induced oscillations (left) at baseline and the response to synaptic stimulation (right). (iv) average stimulation-induced glucose transients from a single experiment in control (black) and following i.c.v. Aβ1-42 injection (red) and summary graph showing glucose transient integral values normalized to controls for all experiments; (v) summary of LFP integrals showing that stimulation response did not change significantly following Aβ1-42 injection; this suggests that the activity-induced increase in glucose supply from the blood did not change, and therefore the apparent increase in glucose transients following Aβ1-42 injection indicates reduced uptake. C Aβ1-42 inhibits activity-driven glycolysis. Left, NAD(P)H autofluorescence traces from a single experiment in control (black) and following 40 min of Aβ1-42 application (red). Right, summary values of transient amplitudes both for the overshoot (glycolysis-related) and oxidation phases of the signal. D Aβ1-42 increases oxygen consumption: sample pO2 traces from a single experiment showing a transient decrease of tissue oxygen levels in control (black) and following 40 min of Aβ1-42 application (red) and a summary plot of normalized pO2 integral values. E Aβ1-42 does not significantly change the network response to synaptic stimulation: a summary plot of normalized LFP train integral values. Data are presented as box plots with min-max whiskers and Tukey quartile method. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.CC BY · PubMed Central
Fig. 2 NOX2 is critical for Aβ1-42–induced disruption of network glucose utilization. A In brain slices, application of NOX2 antagonist GSK2795039 prevents the reduction in network activity-driven glucose uptake caused by Aβ1-42: example traces from a single experiment showing the extracellular glucose transients in CA1 pyramidal cell layer in response to a 10 Hz, 30 s stimulation of Schaffer collaterals (gray) in control (black), after wash-in of GSK2795039 (green), and following 40 min of GSK2795039 + Aβ1-42 application (blue); summary graph showing corresponding glucose transient integral values normalized to controls with those of Aβ1-42 alone for comparison (red). B In anesthetized mice, intraventricular injection of GSK2795039 + Aβ1-42 (blue) preceded by GSK2795039 (green) fails to elicit any changes in glucose uptake. (i) example traces from a single experiment showing both local field potential (LFP, orange) and extracellular glucose (black) recordings from the CA1 region. (ii) average stimulation-induced glucose transients from a single experiment in control (black), following i.c.v. GSK2795039 injection (green) and subsequent injection of GSK2795039 + Aβ1-42 (blue). (iii) the summary graph showing corresponding glucose transient integral values together with those of Aβ1-42 alone for comparison (red). (iv) summary of LFP integral values showing no significant change following either injection. C GSK2795039 prevents Aβ1-42 disruption of activity-driven glycolysis. Left, NAD(P)H autofluorescence traces from a single experiment in control (black) after wash-in of GSK2795039 (green), and following 40 min of GSK2795039 + Aβ1-42 application (blue); Right, summary values of transient amplitudes both for the overshoot (glycolysis-related) and “oxidation” phases of the signal. D GSK2795039 blocks Aβ1-42 induced increase in oxygen consumption: sample pO2 traces from a single experiment showing a transient decrease of tissue oxygen levels in control (black) after wash-in of GSK2795039 (green), and following 40 min of GSK2795039 + Aβ1-42 application (blue); the summary plot of normalized pO2 integral values. E GSK2795039 does not significantly modify network response to stimulation (green), while under Aβ + GSK2795039, the response decreases (blue); summary plot of stimulation train LFP integral values with Aβ-only values for comparison (dotted red). F Aβ1-42 application has no effect in NOX2-deficient mouse slices: sample traces and summary of glucose (i) and NAD(P)H fluorescence transients (ii), as well as summary of changes in oxygen consumption and LFP integrals (iii). Data are presented as box plots with min-max whiskers and Tukey quartile method. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
Fig. 2 NOX2 is critical for Aβ1-42–induced disruption of network glucose utilization. A In brain slices, application of NOX2 antagonist GSK2795039 prevents the reduction in network activity-driven glucose uptake caused by Aβ1-42: example traces from a single experiment showing the extracellular glucose transients in CA1 pyramidal cell layer in response to a 10 Hz, 30 s stimulation of Schaffer collaterals (gray) in control (black), after wash-in of GSK2795039 (green), and following 40 min of GSK2795039 + Aβ1-42 application (blue); summary graph showing corresponding glucose transient integral values normalized to controls with those of Aβ1-42 alone for comparison (red). B In anesthetized mice, intraventricular injection of GSK2795039 + Aβ1-42 (blue) preceded by GSK2795039 (green) fails to elicit any changes in glucose uptake. (i) example traces from a single experiment showing both local field potential (LFP, orange) and extracellular glucose (black) recordings from the CA1 region. (ii) average stimulation-induced glucose transients from a single experiment in control (black), following i.c.v. GSK2795039 injection (green) and subsequent injection of GSK2795039 + Aβ1-42 (blue). (iii) the summary graph showing corresponding glucose transient integral values together with those of Aβ1-42 alone for comparison (red). (iv) summary of LFP integral values showing no significant change following either injection. C GSK2795039 prevents Aβ1-42 disruption of activity-driven glycolysis. Left, NAD(P)H autofluorescence traces from a single experiment in control (black) after wash-in of GSK2795039 (green), and following 40 min of GSK2795039 + Aβ1-42 application (blue); Right, summary values of transient amplitudes both for the overshoot (glycolysis-related) and “oxidation” phases of the signal. D GSK2795039 blocks Aβ1-42 induced increase in oxygen consumption: sample pO2 traces from a single experiment showing a transient decrease of tissue oxygen levels in control (black) after wash-in of GSK2795039 (green), and following 40 min of GSK2795039 + Aβ1-42 application (blue); the summary plot of normalized pO2 integral values. E GSK2795039 does not significantly modify network response to stimulation (green), while under Aβ + GSK2795039, the response decreases (blue); summary plot of stimulation train LFP integral values with Aβ-only values for comparison (dotted red). F Aβ1-42 application has no effect in NOX2-deficient mouse slices: sample traces and summary of glucose (i) and NAD(P)H fluorescence transients (ii), as well as summary of changes in oxygen consumption and LFP integrals (iii). Data are presented as box plots with min-max whiskers and Tukey quartile method. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.CC BY · PubMed Central
Fig. 3 NOX2 mediates Aβ effect on network activity in vivo. A Aβ1-42 i.c.v. injection results in an acute increase in network activity and interictal spike frequency in awake freely moving mice. (i) Example LFP trace from hippocampal CA1 stratum pyramidale before and after Aβ injection. (ii) 20-s accumulated activity integrals analyzed from the top trace. (iii) Interictal spike frequency analyzed from the top trace. B NOX2 blockade prevents Aβ-induced hyperactivity. (i) Example LFP trace from hippocampal CA1 stratum pyramidale in control, following GSK2795039 injection, and after subsequent Aβ injection. (ii) Accumulated activity integrals analyzed from the top trace. (iii) Interictal spike frequency analyzed from the top trace. C Mean 1-h accumulated activity integral and interictal spike rate values for all experiments in A, B. D Aβ-induced hyperactivity persists 48 h following the Aβ injection and is prevented by preceding GSK2795039 application. (i) Average accumulated activity integrals. (ii) Average interictal spike rates. (iii) Average pHFO rates. Data are presented as box plots with min-max whiskers and Tukey quartile method. *p < 0.05, **p < 0.01, ***p < 0.001.
Fig. 3 NOX2 mediates Aβ effect on network activity in vivo. A Aβ1-42 i.c.v. injection results in an acute increase in network activity and interictal spike frequency in awake freely moving mice. (i) Example LFP trace from hippocampal CA1 stratum pyramidale before and after Aβ injection. (ii) 20-s accumulated activity integrals analyzed from the top trace. (iii) Interictal spike frequency analyzed from the top trace. B NOX2 blockade prevents Aβ-induced hyperactivity. (i) Example LFP trace from hippocampal CA1 stratum pyramidale in control, following GSK2795039 injection, and after subsequent Aβ injection. (ii) Accumulated activity integrals analyzed from the top trace. (iii) Interictal spike frequency analyzed from the top trace. C Mean 1-h accumulated activity integral and interictal spike rate values for all experiments in A, B. D Aβ-induced hyperactivity persists 48 h following the Aβ injection and is prevented by preceding GSK2795039 application. (i) Average accumulated activity integrals. (ii) Average interictal spike rates. (iii) Average pHFO rates. Data are presented as box plots with min-max whiskers and Tukey quartile method. *p < 0.05, **p < 0.01, ***p < 0.001.CC BY · PubMed Central
Fig. 4 NOX2 blockade prevents Aβ1-42–induced neuropsychiatric-like behavioral abnormalities. A Timeline diagram of experimental design. B Open field test. Animals were placed in the center of the OF and latent time (sec) of the first run from the central square of 20 × 20 cm was recorded. Such indicators of anxiety as the number of entries into the center (n), the average time in the center (s), and the number of fecal boli (n) are also presented. C Social Interaction test: animals, individually housed for 5 days prior, were placed on a round field for 1 h. (i) Fighting Test: the number of fights, the number of aggressors, and duration of fights are presented. The number of fights and aggressors increased sharply in the Aβ group (red) compared to vehicle group (black). In the Aβ group with daily GSK2795039 injection, not a single fight was recorded during the entire hour of registration (blue). Mice actively interacted, but elements of aggression were absent. (ii) Grouping test: at the same time, direct contact (huddling) between mice was evaluated. Number of mice in a group as well as duration of grouping are presented. Mice in Aβ group (red) spent almost no time grouping, in contrast to the vehicle group (black). GSK2795039 treatment resulted in grouping dynamic improvement to or even over the vehicle levels (blue). *See Supplementary Movie 1 for sample recording of all three groups. D Partition Test. As direct contact with the partition correlates with the level of aggressiveness in mice, we analyzed the number of contacts (right) and time in contact with the partition (left). GSK2795039 (blue) prevented Aβ-induced aggressiveness (red) in mice when compared to vehicle (black). Data are presented as box plots with min-max whiskers and Tukey quartile method. *p < 0.05.
Fig. 4 NOX2 blockade prevents Aβ1-42–induced neuropsychiatric-like behavioral abnormalities. A Timeline diagram of experimental design. B Open field test. Animals were placed in the center of the OF and latent time (sec) of the first run from the central square of 20 × 20 cm was recorded. Such indicators of anxiety as the number of entries into the center (n), the average time in the center (s), and the number of fecal boli (n) are also presented. C Social Interaction test: animals, individually housed for 5 days prior, were placed on a round field for 1 h. (i) Fighting Test: the number of fights, the number of aggressors, and duration of fights are presented. The number of fights and aggressors increased sharply in the Aβ group (red) compared to vehicle group (black). In the Aβ group with daily GSK2795039 injection, not a single fight was recorded during the entire hour of registration (blue). Mice actively interacted, but elements of aggression were absent. (ii) Grouping test: at the same time, direct contact (huddling) between mice was evaluated. Number of mice in a group as well as duration of grouping are presented. Mice in Aβ group (red) spent almost no time grouping, in contrast to the vehicle group (black). GSK2795039 treatment resulted in grouping dynamic improvement to or even over the vehicle levels (blue). *See Supplementary Movie 1 for sample recording of all three groups. D Partition Test. As direct contact with the partition correlates with the level of aggressiveness in mice, we analyzed the number of contacts (right) and time in contact with the partition (left). GSK2795039 (blue) prevented Aβ-induced aggressiveness (red) in mice when compared to vehicle (black). Data are presented as box plots with min-max whiskers and Tukey quartile method. *p < 0.05.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 107 references

Cited by

See all 60

Metadata

Authors
Malkov, A., Popova, I., Ivanov, A., Jang, S.-S., Yoon, S. Y., Osypov, A., Huang, Y., Zilberter, Y., & Zilberter, M.
Affiliations
  • Russian Academy of Sciences (RU)
  • Inserm (FR)
  • Gladstone Institutes (US)
Corresponding author
Zilberter, Misha
Venue
Communications Biology
Published
2021-09-09
Volume
4
Issue
1
Pages
1054-1054
ISSN
2399-3642 (ISSN-L)
OpenAlex
W3198004014
Cited by
59
References
107
Citations by year
2026: 7 · 2025: 18 · 2024: 11 · 2023: 10 · 2022: 10 · 2021: 2
FWCI
5.18
Type
journal article
Language
en
Open access
Licence
Locations
  • Communications Biology (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG061150)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
Alzheimer's disease, amyloid-beta 42, NADPH oxidase 2, oxidative stress, brain glucose hypometabolism, preclinical Alzheimer's disease, behavioral abnormalities
MeSH terms
NADPH Oxidase 2, Aminopyridines, Animals, Brain, Glucose, Hyperkinesis, Male, Sulfonamides, Amyloid beta-Peptides, Oxidative Stress, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Aβ initiates brain hypometabolism, network dysfunction and behavioral abnormalities via NOX2-induced oxidative stress in mice. https://app.cochat.ai/papers/10.1038/s42003-021-02551-x
The paper
Malkov, A., Popova, I., Ivanov, A., Jang, S.-S., Yoon, S. Y., Osypov, A., Huang, Y., Zilberter, Y., & Zilberter, M. (2021). Aβ initiates brain hypometabolism, network dysfunction and behavioral abnormalities via NOX2-induced oxidative stress in mice. Communications Biology. https://doi.org/10.1038/s42003-021-02551-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.